Corona Vaccine For Children: Good news, soon corona vaccine for children, preparation for trial

Corona Vaccine For Children: The work of protecting the vaccine for the people suffering from the corona epidemic is going on, after the age of 18, now the corona vaccine will soon come for children up to two years, preparing for the trial . Corona Vaccine For Children: Vaccines are playing

Corona Vaccine For Children: The work of protecting the vaccine for the people suffering from the corona epidemic is going on, after the age of 18, now the corona vaccine will soon come for children up to two years, preparing for the trial .

Corona Vaccine For Children: Vaccines are playing an important role in the ongoing fight against the corona epidemic in the country, till now corona vaccines are available for the age of 18 years, but in the meantime there is great news that soon For children from 2 years to 18 years, the corona vaccine will be available in the coming day. For this, an expert committee has on Tuesday recommended a trial for the second / third phase of Bharat Biotech’s Kovid-19 Vaccine Kovaxine for the 2-18 age group, as per the information from official sources, the trial of AIIMS in Delhi and Patna and It will be done at various places including the Meditrina Medical Science Institute based in Nagpur. If the trial is successful, then soon the vaccine for children will also come.

Bharat Biotech’s COVID-19 vaccine Covaxin recommended by expert panel for Phase II / III clinical trials on 2 to 18 year-olds: Sources

CDSCO considers application of Bharat Biotech Kovid-19 Subject Expert Committee of Central Drug Standards Control Organization (CDSEO) on Tuesday discussed the application made by Bharat Biotech in which two years to 18 years of its Kovacine vaccine It was requested to allow the second / third phase of the test to assess other things including increasing safety and immunity in children.

Kovaxin is effective on Corona’s double mutants. Let us
know that the American newspaper New York Times reported that covaxin works and is effective in making antibodies against the transforming corona virus. A few days earlier, ICMR and Bharat Biotech, announcing the results of the third trial, said that the covaxine vaccine is up to 78 percent effective on normal corona patients.

Bharat Biotech started sending vaccines to the states,
a source said in a news report that after detailed deliberations on the company’s application, the committee recommended allowing the proposed second / third phase of testing, and after that Bharat Biotech Has started supplying its covid vaccine covicin to all the states of the country. India Biotech company has given its information via tweet. States that are being supplied include Andhra Pradesh, Assam, Chhattisgarh, Delhi, Gujarat, Jammu and Kashmir, Jharkhand, Madhya Pradesh, Maharashtra, Odisha, Tamil Nadu, Telangana, Uttar Pradesh and West Bengal.

Leave a Reply

Your email address will not be published. Required fields are marked *